Takeshi Masuda

USPTO Granted Patents = 50 (Patent Applications = 18)

CIPO Patents = 2

EPO Patents = 13 (Patent Applications = 15)

Average Co-Inventor Count = 4.3

ph-index = 7

Forward Citations = 188(Granted Patents)

Forward Citations (Not Self Cited) = 173(Dec 10, 2025)

Location History:

Narita, JP (1999)
Chuo-ku, JP (2003)
Kodaira, JP (2013)
Nagasaki, JP (2016)
Yokosuka, JP (2021)
Tokyo, JP (1993 - 2024)
Musashino, JP (2018 - 2024)

Company Filing History:

17 out of 441

Daiichi Sankyo Company, Limited

patents

14 out of 5,290

Nippon Telegraph and Telephone Corporation

Sankyo Company, Limited

patents

6. 1 out of 5,124

Bridgestone Corporation

patents

7. 1 out of 613

Sumitomo Bakelite Company Limited

patents

8. 1 out of 38

National Space Development Agency of Japan

patents

9. 1 out of 21,351

Mitsubishi Denki Kabushiki Kaisha

patents

10. 1 out of 5

Kobe Gakuin Educational Foundation

patents

11. 1 out of 21,927

Honda Motor Co., Ltd.

patents

12. 1 out of 4

Parker Industries, Inc.

patents

where one patent can have more than one assignee

Years Active: 1993-2025

Loading Chart...

Areas of Expertise:

Antibody-Drug Conjugates

Tumor Treatment

Claudin-6 Antibody

Pyrrolobenzodiazepine Derivatives

Magnet Structures

Epitaxial Growth

Glycogen Storage Disease

Display Control Devices

R-T-B Permanent Magnets

Debugging Assistance

Liquid Resin Composition

Ceramic Chip Capacitors

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358999 - Protein recognizing drug moiety of antibody-drug conjugate (2025-07-15),

2. 12350344 - Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate (2025-07-08),

3. 12246196 - Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines (2025-03-11),

4. 12186310 - Antibody-drug conjugate (2025-01-07),

5. 12124353 - Operation logs acquiring device, operation logs acquiring method, and operation logs acquiring program (2024-10-22),

6. 12086740 - Management device, management method, and management program (2024-09-10),

7. 12007872 - Debugging assistance system and debugging assistance method (2024-06-11),

8. 11960711 - Display control device, display control method, and display control program (2024-04-16),

9. 11958878 - Therapeutic agent for glycogen storage disease type IA (2024-04-16),

10. 11875024 - User operation recording device and user operation recording method (2024-01-16),

11. 11861417 - Operation support system, operation support method, and operation support program (2024-01-02),

12. 11817241 - Magnet structure (2023-11-14),

13. 11797553 - Timeline display device, timeline display method and timeline display program (2023-10-24),

14. 11797163 - Display control device and display control method for displaying images including electronic labels (2023-10-24),

15. 11795236 - Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate (2023-10-24),

Title: The Innovative Journey of Takeshi Masuda

Introduction: Takeshi Masuda is a pioneering inventor hailing from Tokyo, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Takeshi Masuda's recent patents include advancements in artificial intelligence algorithms for autonomous vehicles, sustainable energy solutions, and medical device innovations.

Career Highlights: With over two decades of experience in research and development, Masuda has led numerous successful projects that have resulted in patented inventions that have significantly impacted industries worldwide.

Collaborations: Throughout his career, Takeshi Masuda has collaborated with leading research institutions, universities, and multinational companies to push the boundaries of innovation and bring cutting-edge technologies to life.

Conclusion: Takeshi Masuda's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor in the global technological landscape.

This text is generated by artificial intelligence and may not be accurate.